How much does pharmaceutical industry control what appears in medical literature?

Posted on October 11, 2007 by | 2 Comments

Ghosts, drugs, and blogs:

By its hidden nature, it is obviously a challenge to determine the exact prevalence of “ghost management,” defined by Sismondo as the phenomenon in which “pharmaceutical companies and their agents control or shape multiple steps in the research, analysis, writing, and publication of articles.”

Of course they fight against Open Access Publishing – too much sunshine scares them and would make them scurry away in panic…

This entry was posted in Academia, Medicine, Open Science, Science Practice. Bookmark the permalink.

2 responses to “How much does pharmaceutical industry control what appears in medical literature?”

  1. Robert H Pflanz's avatar Robert H Pflanz | October 11, 2007 at 5:33 pm |

    The best way to insure profits for your company is to eliminate any competition. If you can control the press, then any alternative to your product can never be recognized by the public and you effectively eliminate your competition. If you can’t lick them, you buy them. If you can’t buy them, you eliminate them. Control the press, control the politics, control the market.

  2. Fda Clinical Trial's avatar Fda Clinical Trial | April 30, 2009 at 9:36 am |

    Thanks for this great post!!!!!!!!!!!!!!